X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
female (62) 62
male (62) 62
middle aged (59) 59
urology & nephrology (56) 56
albuminuria (48) 48
aged (47) 47
risk factors (42) 42
diabetes (37) 37
endocrinology & metabolism (37) 37
glomerular filtration rate (33) 33
type 2 diabetes (33) 33
diabetes mellitus (30) 30
mortality (29) 29
blood-pressure (28) 28
chronic kidney disease (28) 28
diabetes mellitus, type 2 - complications (28) 28
nephropathy (28) 28
risk (28) 28
adult (25) 25
disease progression (25) 25
diabetes mellitus, type 2 - drug therapy (24) 24
chronic kidney-disease (23) 23
progression (23) 23
kidney diseases (21) 21
blood pressure (20) 20
creatinine (20) 20
glomerular-filtration-rate (20) 20
double-blind method (19) 19
empagliflozin (19) 19
hypertension (19) 19
treatment outcome (19) 19
clinical trials (18) 18
disease (18) 18
nephrology (18) 18
proteinuria (18) 18
sodium (18) 18
cardiovascular diseases (17) 17
diabetic nephropathies - drug therapy (17) 17
analysis (16) 16
chronic kidney failure (16) 16
dapagliflozin (16) 16
microalbuminuria (16) 16
outcomes (16) 16
biomarkers - blood (15) 15
diabetes mellitus, type 2 - blood (15) 15
double-blind (15) 15
biomarkers (14) 14
kidney-disease (14) 14
research (14) 14
abridged index medicus (13) 13
cardiac & cardiovascular systems (13) 13
care and treatment (13) 13
diabetic nephropathies (13) 13
diabetic nephropathy (13) 13
kidney - physiopathology (13) 13
kidneys (13) 13
umcg approved (13) 13
angiotensin (12) 12
canagliflozin (12) 12
diabetic-nephropathy (12) 12
glomerular filtration rate - drug effects (12) 12
medical research (12) 12
original (12) 12
original articles (12) 12
patients (12) 12
peripheral vascular disease (12) 12
population (12) 12
post-hoc analysis (12) 12
albumin (11) 11
cardiovascular disease (11) 11
development and progression (11) 11
diabetes mellitus, type 2 - physiopathology (11) 11
diabetic nephropathies - physiopathology (11) 11
drug therapy (11) 11
heart-failure (11) 11
losartan (11) 11
prognosis (11) 11
renal insufficiency, chronic - physiopathology (11) 11
transplantation (11) 11
albuminuria - physiopathology (10) 10
cardiovascular diseases - prevention & control (10) 10
hypoglycemic agents - therapeutic use (10) 10
kidney (10) 10
kidney - drug effects (10) 10
medicine, experimental (10) 10
prospective studies (10) 10
randomized controlled trials as topic (10) 10
sodium-glucose transporter 2 inhibitors - therapeutic use (10) 10
stage renal-disease (10) 10
urologic and male genital diseases (10) 10
albuminuria - complications (9) 9
biomarkers - urine (9) 9
cardiovascular events (9) 9
cardiovascular outcomes (9) 9
cardiovascular-disease (9) 9
ckd (9) 9
complications and side effects (9) 9
diabetic kidney disease (9) 9
diabetic nephropathies - blood (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Levin, Adeera and Tonelli, Marcello and Bonventre, Joseph and Coresh, Josef and Donner, Jo-Ann and Fogo, Agnes B and Fox, Caroline S and Gansevoort, Ron T and Heerspink, Hiddo J L and Jardine, Meg and Kasiske, Bertram and Köttgen, Anna and Kretzler, Matthias and Levey, Andrew S and Luyckx, Valerie A and Mehta, Ravindra and Moe, Orson and Obrador, Gregorio and Pannu, Neesh and Parikh, Chirag R and Perkovic, Vlado and Pollock, Carol and Stenvinkel, Peter and Tuttle, Katherine R and Wheeler, David C and Eckardt, Kai-Uwe and Adu, Dwomoa and Agarwal, Sanjay Kumar and Alrukhaimi, Mona and Anders, Hans-Joachim and Ashuntantang, Gloria and Basnet, Shakti and Bello, Aminu K and Chailimpamontree, Worawon and Correa-Rotter, Ricardo and Craig, Jonathan and Douthat, Walter G and Feldman, Harold I and Ganji, Mohammad Reza and Garcia-Garcia, Guillermo and Gharbi, Mohammed Benghanem and Harris, David C and Jha, Vivekanand and Johnson, David W and Kazancioglu, Rumeyza and Langham, Robyn and Liu, Zhi-Hong and Massy, Ziad A and Nangaku, Masaomi and Nelson, Robert G and O'Donoghue, Donal and Okpechi, Ikechi and Pecoits-Filho, Roberto and Powe, Neil R and Remuzzi, Giuseppe and Roberts, Charlotte and Rossert, Jerome and Sola, Laura and Stengel, Benedicte and M, Ernest K. Sumaili and Suzuki, Yusuke and Tanaka, Tetsuhiro and Tatiyanupanwong, Sajja and Thomas, Bernadette and Uhlig, Katrin and Walker, Robert and White, Sarah L and Wiecek, Andrzej and Yang, Chih-Wei and ISN Global Kidney Health Summit participants and ISN Global Kidney Hlth Summit
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10105, pp. 1888 - 1917
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 24, pp. 2295 - 2306
Journal Article
Kidney international, ISSN 0085-2538, 2011, Volume 80, Issue 3, pp. 282 - 287
Journal Article
Clinical journal of the American Society of Nephrology, ISSN 1555-905X, 2017, Volume 12, Issue 5, pp. 751 - 759
BACKGROUND AND OBJECTIVE: Sodium glucose cotransporter 2 inhibition with dapagliflozin decreases hemoglobin A1c (HbA1c), body weight, BP, and albuminuria... 
REDUCES ALBUMINURIA | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | CONTROLLED 102-WEEK TRIAL | COTRANSPORTER 2 INHIBITION | CHRONIC KIDNEY-DISEASE | TYPE-2 DIABETES-MELLITUS | POST-HOC ANALYSIS | INADEQUATE GLYCEMIC CONTROL | BLOOD-PRESSURE | Cardiovascular Diseases | Body Weight | Benzhydryl Compounds | Cardiovascular | Humans | Hematocrit | Albuminuria | Risk factors | Glomerular filtration rate | Hypoglycemic Agents | Diabetic nephropathy | Blood pressure | Diabetes Mellitus, Type 2 | Natriuresis | Glucosides | KIDNEY-DISEASE | BODY-WEIGHT | SODIUM RESTRICTION | UROLOGY & NEPHROLOGY | Albuminuria - epidemiology | Biomarkers - urine | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Middle Aged | Male | Diabetes Mellitus, Type 2 - epidemiology | Protective Factors | Albuminuria - physiopathology | Clinical Trials, Phase III as Topic | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - epidemiology | Female | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Glucosides - adverse effects | Hypoglycemic Agents - therapeutic use | Kidney Tubules, Proximal - pathology | Glomerular Filtration Rate | Risk Assessment | Sodium-Glucose Transporter 2 - metabolism | Risk Factors | Hemoglobins - metabolism | Treatment Outcome | Biomarkers - blood | Albuminuria - prevention & control | Creatinine - urine | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Randomized Controlled Trials as Topic | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Kidney Tubules, Proximal - metabolism | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Kidney Tubules, Proximal - drug effects | blood pressure | risk factors | glomerular filtration rate | cardiovascular | albuminuria | Original | diabetic nephropathy
Journal Article
Clinical journal of the American Society of Nephrology, ISSN 1555-9041, 10/2017, Volume 12, Issue 10, pp. 1595 - 1600
Background and objectives: RRT and doubling of serum creatinine are considered the objective hard end points in nephrology intervention trials. Because both... 
SERUM CREATININE |